This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $1200

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA
Book Now
Menu
Book

Nadia Cumbal
Principal Scientist at Intellia Therapeutics
Speaker

Profile

Nadia obtained her PhD in Molecular and Systems Biology from Dartmouth College before joining Intellia Therapeutics as a Scientist in 2019. Nadia is currently a Principal Scientist in the Chemistry and Delivery Sciences group. As such, she is responsible for assay development, new technology and process evaluation, managing R&D small-scale production to support diverse programs. Her scientific interests encompass RNA biology, synthetic and structural biology.

Agenda Sessions

  • RNA Technologies That Drive CRISPR-Cas9 Editing

    , 4:45pm
    View Session

At this event

Prev
Next
Daniel DeOliveira, PhD
Vice President, Drug Substance Development and Manufacturing
Kailera Therapeutics

See Nadia at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now